Electrical stimulation and blood flow restriction increase wrist extensor cross-sectional area and flow meditated dilatation following spinal cord injury.
Ashraf S Gorgey, Mark K Timmons, David R Dolbow...
https://pubmed.ncbi.nlm.nih.gov/27155846/Actively Recruiting
Led by Ankara Yildirim Beyazıt University · Updated on 2026-10-28
52
Participants Needed
1
Research Sites
N/A
Total Duration
Lateral epicondylitis is a chronic tendon condition causing pain, tenderness, and reduced grip strength on the outer elbow. Researchers are comparing the effects of extracorporeal shock wave therapy ESWT alone versus ESWT combined with blood flow restriction therapy BFR in adults diagnosed with this condition. The study aims to improve pain management, muscle strength, and functional recovery through these treatments, contributing new knowledge to physical therapy and rehabilitation. Participants are divided into two groups receiving treatment once a week for four weeks. One group gets ESWT alone, where treatment intensity is adjusted based on pain tolerance. The other group receives both ESWT and BFR, which involves applying pressure to restrict blood flow during low-intensity upper extremity exercises to promote muscle strength and tissue healing. Both therapies are performed using specialized devices and techniques. Before and after the treatment period, researchers assess pain levels, grip strength, wrist muscle strength, and upper limb function. Muscle strength is also measured at eight weeks to track progress. These evaluations help analyze how the treatments affect symptoms and function. The total participation duration includes treatment and follow-up assessments to monitor outcomes and safety.
CONDITIONS
A Comparison of the Effects of Combining ESWT With Blood Flow Restriction Therapy in Patients Diagnosed With Lateral Epicondylitis
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ankara Yildirim Beyazıt University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants receive extracorporeal shock wave therapy (ESWT) alone or combined with blood flow restriction therapy (BFR) once a week for 4 weeks. ESWT intensity is adjusted based on pain tolerance, and BFR includes low-intensity upper extremity exercises under restricted blood flow.
1 visit per week for 4 weeks
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Ashraf S Gorgey, Mark K Timmons, David R Dolbow...
https://pubmed.ncbi.nlm.nih.gov/27155846/Lei Zhang, Xinyi Zhang, Long Pang...
https://pubmed.ncbi.nlm.nih.gov/39198038/Dafang Zhang, Cathal J Kearney, Thomas Cheriyan...
https://pubmed.ncbi.nlm.nih.gov/22009294/Stephen D Patterson, Luke Hughes, Stuart Warmington...
https://pubmed.ncbi.nlm.nih.gov/31156448/Frank A Pettrone, Brian R McCall
https://pubmed.ncbi.nlm.nih.gov/15930540/Wilson C Lai, Brandon J Erickson, Ryan A Mlynarek...
https://pubmed.ncbi.nlm.nih.gov/30464656/Rahman Shiri, Eira Viikari-Juntura, Helena Varonen...
https://pubmed.ncbi.nlm.nih.gov/16968862/B S Kraushaar, R P Nirschl
https://pubmed.ncbi.nlm.nih.gov/10073590/Mohan Kumar G, Nishanthi S, Kamatchi K...
https://pubmed.ncbi.nlm.nih.gov/38957235/Sadiye Murat, Bilinc Dogruoz Karatekin, Melisa Zengin
https://pubmed.ncbi.nlm.nih.gov/38940482/Ankara Yildirim Beyazıt University
Lead Sponsor